COFEPRIS News Today: Latest Updates and Alerts
If you are searching for cofepris news today, you are likely looking for recent updates from Mexico’s federal health regulator, including medical device registrations, drug safety, health alerts, clinical trials, regulatory changes, and digital services.
This page tracks the latest verified developments from COFEPRIS, formally known as the Comisión Federal para la Protección contra Riesgos Sanitarios. The most recent official COFEPRIS publications available as of September 1, 2026 include updates on medical device registration, the FEUM 14.0 pharmacopeia, DIGIPRiS, pharmacovigilance, clinical trials, and sanitary surveillance.
Last checked: September 1, 2026.
Quick Answer:
What Is the Latest COFEPRIS News Today?
The latest verified COFEPRIS information available today is focused mainly on regulatory services, medical devices, pharmaceutical quality, digitalization, clinical research, and health surveillance. Recent official updates include a new medical device registration viewer, publication of the FEUM 14.0 pharmacopeia, clarification about DIGIPRiS, updated clinical-trial information, and continued pharmacovigilance work.
Because COFEPRIS updates its information frequently, “today’s news” can change during the day. This page therefore separates recent developments from older background information.
Table of Contents
- What is COFEPRIS?
- Latest COFEPRIS news today
- New medical device registration viewer
- FEUM 14.0 pharmacopeia update
- Latest DIGIPRiS update
- Pharmacovigilance and drug safety news
- Clinical trial and research updates
- Recent food safety and sanitary surveillance news
- COFEPRIS regulatory changes in 2026
- What COFEPRIS regulates
- Why COFEPRIS news matters to businesses
- How to check a COFEPRIS registration
- COFEPRIS alerts and safety information
- COFEPRIS news for medical device companies
- COFEPRIS news for pharmaceutical companies
- Common mistakes when following COFEPRIS news
- Frequently asked questions
- Key takeaways
What Is COFEPRIS?
Mexico’s federal agency in charge of safeguarding citizens against health hazards associated with regulated goods, services, and activities is COFEPRIS.
Medicines, medical equipment, food, drinks, cosmetics, pesticides, health services, advertising, and other goods or activities that may have an impact on public health are all covered by its work. According to the Mexican government, COFEPRIS surveillance, control, and regulation apply to operations in the regulated sector.
According to Emergo by UL, COFEPRIS is the Mexican federal agency in charge of sanitary control, which covers imports, exports, advertising, manufacturing, pharmaceuticals, and medical devices. (Emergo by UL)
COFEPRIS can therefore be a crucial step in the market-entry and compliance process for companies who import or sell health-related goods into Mexico.
Latest COFEPRIS News Today
The most important recent official developments include the following:
| Date | COFEPRIS development | Why it matters |
|---|---|---|
| August 28, 2026 | Updated sanitary registration procedures and information | Useful for companies managing product registrations |
| August 26, 2026 | New clinical-trial information and support materials | Helps researchers and sponsors understand current processes |
| August 25, 2026 | FEUM 14.0 published | Important for pharmaceutical quality and standards |
| August 25, 2026 | DIGIPRiS clarification issued | Addresses claims about the digital platform |
| August 20, 2026 | Medical device registration viewer launched | Makes public registration checks easier |
| August 18, 2026 | National pharmacovigilance and technovigilance bulletin published | Provides safety-monitoring information |
| August 10, 2026 | National Federal Health System meeting held | Highlights regulatory coordination and modernization |
These developments appear in the recent COFEPRIS publication archive and official government pages.
New COFEPRIS Medical Device Registration Viewer
The introduction of the Medical Device Sanitary Registration Viewer, or Visor de Registros Sanitarios de Dispositivos Españicos, is one of the most significant recent developments.
On August 20, 2026, COFEPRIS made the tool public. According to the agency, the viewer makes information regarding legitimate sanitary registrations for medical devices accessible to the general public and healthcare facilities. The purpose of the tool is to facilitate the consultation and verification of registration information.
What is the significance of the medical device viewer?
Distributors, medical device manufacturers, healthcare organizations, and other interested parties frequently need to confirm whether a product has a valid sanitary registration.
Because users can verify registration details without depending solely on private databases or third-party summaries, a public search engine can facilitate this process.
Additionally, the audience is in favor of more openness about medical device regulations.
What does it teach users?
The purpose of the tool is to make information on current medical device sanitary registrations accessible to the general public.
The registration status of a medical device can be a crucial component of regulatory due diligence for a business assessing it for the Mexican market.
It is nonetheless crucial to realize that reviewing a registration record does not equate to finishing the regulatory procedure in its entirety.
[PSD3 and PSR News Today: Key Updates You Need to Know]
COFEPRIS and the FEUM 14.0 Pharmacopeia Update
Another major recent development is the publication of FEUM 14.0, the 14th edition of the Farmacopea de los Estados Unidos Mexicanos.
COFEPRIS and the Comisión Permanente de la Farmacopea de los Estados Unidos Mexicanos announced the publication on August 25, 2026. According to the official announcement, the new edition includes clearer criteria, analytical methods, and specifications intended to support more efficient sanitary regulation.
What is the FEUM?
The Mexican Pharmacopeia is an important reference for quality standards related to medicines and health products.
Pharmacopeial standards can help establish scientific and technical requirements for product quality.
The FEUM is therefore relevant to companies involved in pharmaceutical manufacturing, quality control, testing, and regulatory compliance.
Why is FEUM 14.0 important?
The updated edition can matter because pharmaceutical standards must remain aligned with scientific and regulatory needs.
COFEPRIS stated that the new edition is based on clear, verifiable, and reproducible scientific criteria. It also said harmonized pharmacopeial standards can support medicine quality, commercial exchange, and international sanitary surveillance.
Companies affected by the relevant standards should review the official requirements rather than relying on summaries or old regulatory information.
Latest DIGIPRiS News
Another significant component of recent COFEPRIS news is DIGIPRiS.
A digital platform called DIGIPRiS helps with the administration and processing of sanitary regulations.
A clarification on information that had been distributed about the platform was released by COFEPRIS on August 25, 2026.
The agency claimed that it was untrue that Mexico’s Superior Audit Office had calculated a diversion of 71.5 million pesos for the building of DIGIPRiS. COFEPRIS clarified that the amount reported in the report was calculated by adding the total value of two contracts between COFEPRIS and the National Polytechnic Institute. According to the agency, the audit authority’s findings have been taken into consideration and fixed.
What makes the DIGIPRiS upgrade crucial?
The way businesses submit and handle regulatory procedures may be impacted by digital regulatory systems.
COFEPRIS has persisted in its pursuit of more digital services. Support guides and frequently asked questions for the DIGIPRiS platform are also recent official materials.
For regulated enterprises, the practical question is not merely if a digital platform exists. It also involves whether the right form, process, supporting documentation, and legal requirement are being followed.
Pharmacovigilance and Drug Safety News
COFEPRIS published its National Pharmacovigilance and Technovigilance Bulletin 2026-I on August 18, 2026.
The bulletin covers monitoring of medicines, vaccines, and medical devices. COFEPRIS said the publication contains three main sections and 16 chapters covering subjects related to medicine and device safety.
What is pharmacovigilance?
Pharmacovigilance is the monitoring of medicines to identify and evaluate safety information after products are used.
It can involve the collection and assessment of reports about suspected adverse reactions and other safety signals.
What is technovigilance?
Technovigilance focuses on the safety and performance of medical devices.
Monitoring can help identify potential problems with devices after they are placed on the market.
These systems matter because regulatory oversight does not end when a product receives authorization.
Post-market monitoring is an important part of product safety.
Clinical Trial and Research Updates
COFEPRIS has also updated its public information about clinical trials.
On August 26, 2026, the agency published material explaining the process for authorization of clinical trial protocols and amendments or modifications. The information covers applications for authorization of research protocols and changes to previously authorized protocols.
COFEPRIS also maintains public information about authorized clinical trials through the Registro Nacional de Ensayos Clínicos, or RNEC.
The agency states that the registry was implemented to promote transparency and public access to information about authorized clinical trials in Mexico. RNEC 2.0 was launched in December 2023 as part of the digitalization of clinical research information.
Why clinical trial news matters
Clinical research requires regulatory oversight because studies involving people must meet applicable scientific, ethical, and regulatory requirements.
For sponsors, researchers, and institutions, accurate information about the current submission process can help them understand what COFEPRIS expects.
[COFEPRIS and Mexico Health Regulation Overview]
Recent Food Safety and Sanitary Surveillance News
COFEPRIS has also been active in food safety and sanitary surveillance.
Its recent August 2026 publication archive includes updates concerning Cyclospora, Salmonella Javiana, food safety investigations, and sanitary surveillance.
In July 2026, COFEPRIS reported that neither Mexico nor the United States had found Cyclospora cayetanensis in lettuce of Mexican origin during an investigation into an outbreak.
COFEPRIS also investigated a jalapeño pepper packing facility in Nuevo León in August. The investigation was part of the agency’s sanitary surveillance activities.
Why food safety updates matter
Food-related COFEPRIS news can affect consumers, food manufacturers, importers, exporters, retailers, and hospitality businesses.
A sanitary alert does not always mean that every product in a category is unsafe. The exact product, batch, location, manufacturer, and regulatory finding matter.
This is why official notices should be checked before making conclusions based on social media posts or headlines.
COFEPRIS Regulatory Changes in 2026
Throughout 2026, COFEPRIS has been working on administrative simplification and regulatory modernization.
One instance occurred in March when COFEPRIS declared that formal assessment would no longer be required for some sanitary import notices. According to the agency, under the specified procedure, these self-managed notices would receive the pertinent document within a maximum of 24 working hours.
Additionally, COFEPRIS implemented electronic email alerts for regulatory processes. The government released a formal email notification permission format for COFEPRIS procedures in February 2026.
These modifications are a part of a larger trend toward less administrative work and digital services.
What Does COFEPRIS Regulate?
COFEPRIS regulates a broad range of health-related products and activities.
These include:
- Medicines
- Medical devices
- Food and beverages
- Cosmetics
- Pesticides
- Health services
- Supplements
- Pharmaceutical products
- Certain advertising activities
- Health-related establishments
- Other products and activities associated with sanitary risks
The Mexican government describes COFEPRIS as responsible for surveillance, control, and regulation of a wide range of sectors connected to public health.
The exact regulatory requirements depend on the product and activity.
Why COFEPRIS News Matters to Businesses
COFEPRIS updates can have practical consequences for companies operating in or entering the Mexican market.
A regulatory change can affect:
- Product registration
- Importation
- Manufacturing
- Labeling
- Advertising
- Medical device compliance
- Pharmaceutical quality
- Clinical research
- Post-market surveillance
- Regulatory submissions
For this reason, businesses should distinguish between general COFEPRIS news and changes that directly apply to their specific product or activity.
A news report may describe a broad policy development, while the actual legal requirement may be contained in a specific regulation, official notice, authorization, or technical document.
How to Check a COFEPRIS Registration
If you need to verify a product, the first step is to identify exactly what type of product you are checking.
Step 1: Identify the product category
Determine whether the product is a medicine, medical device, food product, cosmetic, supplement, or another regulated product.
Step 2: Identify the relevant registration
COFEPRIS provides information about sanitary registrations and related procedures. Its current registration information includes medicines, medical devices, pesticides, plant nutrients, and other categories.
Step 3: Check the current status
A registration should be checked for its current status rather than relying on an old document or third-party statement.
Step 4: Confirm the product details
Check that the registration information corresponds to the actual product, manufacturer, holder, and other relevant details.
Step 5: Review current regulatory information
A valid registration does not remove every other regulatory obligation.
Depending on the product, there may also be requirements involving labeling, advertising, manufacturing, importation, post-market surveillance, or other controls.
COFEPRIS Alerts and Safety Information
COFEPRIS maintains public information covering sanitary alerts, medicines, food products, establishments, and other regulatory actions.
Its recent document archive includes medicine alerts, food alerts, international sanitary alerts, establishment closures, and information about irregular medicine distributors.
This information is especially important for companies and consumers who need to verify whether a specific product or business has been affected by regulatory action.
Do not rely only on a headline
A headline can leave out important details.
When reviewing a sanitary alert, check:
- Product name
- Manufacturer
- Batch or lot information
- Date
- Reason for the alert
- Geographic scope
- Regulatory action
- Instructions issued by the authority
This provides a much more accurate picture of the situation.
COFEPRIS News for Medical Device Companies
The latest COFEPRIS revisions should be closely monitored by medical device manufacturers.
Because it gives the public access to data regarding current sanitary registrations, the new medical device registration viewer is very pertinent.
Additionally, COFEPRIS keeps data on technical standards and laws pertaining to medical devices.
For instance, NOM-137-SSA1-2025 on medical device labeling is listed on its medical device information page. According to the page, the standard was released on May 19, 2026, and it became effective on May 14, 2027.
This demonstrates the need for companies to distinguish between a rule’s publication and its implementation.
COFEPRIS News for Pharmaceutical Companies
Pharmaceutical businesses should watch several areas of COFEPRIS activity.
The most important current areas include:
- Pharmaceutical registration.
- FEUM standards.
- Pharmacovigilance.
- Regulatory submissions.
- Post-market surveillance.
- Digital regulatory procedures.
- Safety alerts.
- Manufacturing and quality requirements.
The publication of FEUM 14.0 is particularly relevant to pharmaceutical quality because the new edition contains updated criteria, analytical methods, and specifications.
The 2026-I pharmacovigilance bulletin is also important because it covers medicine and vaccine safety monitoring and related risk-management activities.
What Is Changing in COFEPRIS Regulation?
The recent pattern of official updates shows several major areas of focus:
| Area | Recent direction |
|---|---|
| Digital services | Greater use of digital regulatory tools |
| Medical devices | Easier public access to registration information |
| Clinical research | Expanded online information and support |
| Pharmaceutical quality | Updated pharmacopeial standards |
| Safety monitoring | Continued pharmacovigilance and technovigilance |
| Administrative processes | Efforts to simplify selected procedures |
| Transparency | More public regulatory information |
These are not all the same type of regulatory change. Some are new tools, some are informational resources, and others are policy or administrative measures.
That distinction matters when determining whether a development creates a new legal requirement.
Common Mistakes When Following COFEPRIS News
Mistake 1: Treating every headline as a new regulation
A press release, clarification, public information page, and binding regulatory requirement are not necessarily the same thing.
Always identify the type of official document.
Mistake 2: Using old registration information
Regulatory information can change.
A document found through an old search result may not show the current status of a product.
Mistake 3: Confusing a registration with full compliance
A sanitary registration is only one part of regulatory compliance.
Other obligations may apply depending on the product and activity.
Mistake 4: Relying on social media summaries
Social media can spread incomplete or incorrect information.
For important regulatory decisions, the original COFEPRIS publication should be checked.
Mistake 5: Ignoring effective dates
A regulation can be published before it becomes effective.
The difference can be important for companies planning compliance activities.
Mistake 6: Assuming one rule applies to every product
COFEPRIS regulates many different product categories.
Requirements for a medicine may be very different from requirements for a medical device, food product, or cosmetic.
How to Read a COFEPRIS News Update Correctly
When you see a new COFEPRIS announcement, use this simple framework:
What happened?
Identify the exact action announced by COFEPRIS.
When did it happen?
Check the publication date and, where relevant, the effective date.
Who is affected?
Determine whether the update concerns consumers, manufacturers, importers, researchers, healthcare organizations, or another group.
What product or activity is involved?
Do not assume that an announcement applies to every regulated product.
Is it a regulation, alert, clarification, tool, or informational update?
This distinction is critical.
What should be checked next?
Look at the actual official document and supporting requirements before making a compliance decision.
Frequently Asked Questions About COFEPRIS News Today
What is the latest COFEPRIS news today?
The latest verified COFEPRIS information available as of September 1, 2026 includes recent updates to medical device registration information, FEUM 14.0, DIGIPRiS, clinical trial resources, and pharmacovigilance. The most recent official archive entries are from late August 2026.
What is COFEPRIS?
COFEPRIS is Mexico’s federal authority for protection against sanitary risks. It regulates and monitors a wide range of health-related products and activities, including medicines, medical devices, food, cosmetics, and other regulated sectors.
What is the new COFEPRIS medical device viewer?
The medical device registration viewer is a public tool announced by COFEPRIS on August 20, 2026. It allows users to consult information about valid sanitary registrations for medical devices.
What is FEUM 14.0?
FEUM 14.0 is the 14th edition of the Farmacopea de los Estados Unidos Mexicanos. COFEPRIS and the Mexican Pharmacopeia commission announced it on August 25, 2026. It includes updated criteria, analytical methods, and specifications related to pharmaceutical quality.
What is DIGIPRiS?
DIGIPRiS is a digital platform used by COFEPRIS to support the processing and management of sanitary regulatory procedures. COFEPRIS published a clarification about information concerning the platform on August 25, 2026.
Where can I find COFEPRIS medical device registration information?
COFEPRIS launched a medical device registration viewer in August 2026 that provides public access to information about valid sanitary registrations.
Does COFEPRIS regulate medicines?
Yes. Medicines are among the products subject to COFEPRIS sanitary regulation and registration requirements. COFEPRIS maintains information covering sanitary registration procedures for medicines and other regulated products.
Does COFEPRIS regulate food?
Yes. Food and beverages are among the sectors subject to COFEPRIS sanitary surveillance and regulation.
What is pharmacovigilance?
Pharmacovigilance is the monitoring of medicine safety. It helps identify and evaluate safety information associated with medicines after they are used.
What is technovigilance?
Technovigilance is related to monitoring the safety and performance of medical devices. It is part of the broader system used to identify and manage potential health risks.
Where can I find clinical trial information?
COFEPRIS provides public information through its Registro Nacional de Ensayos Clínicos. The agency also publishes guidance and support information for clinical trial authorization procedures.
Can COFEPRIS news affect companies in the United States?
Yes. Companies based outside Mexico may need to understand COFEPRIS requirements when they manufacture, import, distribute, advertise, or otherwise handle regulated health products in Mexico.
The exact requirements depend on the product and activity.
Key Takeaways
The current cofepris news today picture is centered on regulatory modernization, transparency, product safety, and digital services.
The most important recent developments are:
- COFEPRIS launched a public viewer for medical device sanitary registrations.
- COFEPRIS and CPFEUM announced FEUM 14.0 on August 25, 2026.
- COFEPRIS issued a clarification concerning DIGIPRiS on August 25, 2026.
- COFEPRIS published its 2026-I national pharmacovigilance and technovigilance bulletin.
- COFEPRIS continues to expand public information about clinical trials and regulatory procedures.
- Recent food safety and sanitary surveillance work has included investigations and public updates involving Cyclospora and Salmonella-related concerns.
- COFEPRIS continues to update sanitary registration and regulatory information for medicines, medical devices, pesticides, and other products.
The key point is that COFEPRIS news should always be read in context. A press release, safety alert, digital service update, registration record, and formal regulatory requirement can have very different meanings.
For the most current information, this article should be treated as a dated news update rather than a permanent record of “today’s” developments. COFEPRIS can publish new information after this page is updated.